[Neuroleptics, thymoleptics and tranquilizers in neurological therapy].
D001480:Basal Ganglia Diseases / Q000188:drug therapy; D002707:Chlordiazepoxide; D002746:Chlorpromazine; D003975:Diazepam; D004827:Epilepsy / Q000188:drug therapy; D005116:Extrapyramidal Tracts; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006801:Humans; D006919:Hydroxyzine; D008620:Meprobamate; D008881:Migraine Disorders / Q000188:drug therapy; D009069:Movement Disorders / Q000188:drug therapy; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000188:drug therapy*; D009468:Neuromuscular Diseases / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D010640:Phenothiazines; D011395:Promazine; D013843:Thiazines; D013847:Thiethylperazine; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D014717:Vertigo / Q000188:drug therapy; D014839:Vomiting / Q000188:drug therapy
D005730:Ganglionic Blockers; D009125:Muscle Relaxants, Central; D010640:Phenothiazines; D013843:Thiazines; D014149:Tranquilizing Agents; D006919:Hydroxyzine; D002707:Chlordiazepoxide; D013847:Thiethylperazine; D008620:Meprobamate; D011395:Promazine; D003975:Diazepam; D002746:Chlorpromazine
Neuroleptika, Thymoleptika und Tranquillantien in der neurologischen Therapie.